Top Markets
#1 Resolv wstUSR Resolv wstUSR +114.61%
#2 Luxxcoin Luxxcoin +45.15%
#3 ResearchCoin ResearchCoin +21.62%
#4 Reactive Network Reactive Network +21.45%
#5 Layer3 Layer3 +19.67%
#6 Orderly Network Orderly Network +16.55%
#7 Aria.AI Aria.AI +12.61%
#8 Bitgert Bitgert +11.76%
#9 Lisk Bridged wstETH (Lisk) Lisk Bridged wstETH (Lisk) +9.32%
#10 KAITO KAITO +9.04%
Coin of the day
Resolv wstUSR Resolv wstUSR
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
CSL Limited CSL Limited

CSL Limited

CSL
Classement en actions #432
CSL Limited researches, develops, manufactures, markets, and distributes... CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.
Prix de l'action
$99.32
Capitalisation boursière
$48.20B
Changement (1 jour)
0.98%
Changement (1 an)
-32.14%
Pays
AU
Échange CSL Limited (CSL)

Catégorie

Healthcare
EPS pour CSL Limited (CSL)
EPS au December 2025 TTM : $2.98
Selon les derniers rapports financiers et le cours de l'action de CSL Limited, l’EPS actuel de la société (TTM) est de $2.98. À la fin de 2024, la société avait un EPS de $5.47 une augmentation par rapport à celui de 2023, qui était de $4.55.
Historique de l'EPS de CSL Limited de 2000 à 2026
EPS à la fin de chaque année
Année EPS Changez
2026 (TTM) $2.98 -51.94%
2025 $6.20 13.35%
2024 $5.47 20.22%
2023 $4.55 -31.37%
2022 $6.63 26.05%
2021 $5.26 13.61%
2020 $4.63 9.20%
2019 $4.24 50.89%
2018 $2.81 -4.42%
2017 $2.94 9.29%
2016 $2.69 -7.88%
2015 $2.92 8.15%
2014 $2.70 21.09%
2013 $2.23 12.45%
2012 $1.98 -0.58%
2011 $1.99 49.05%
2010 $1.34 6.70%
2009 $1.25 7.16%
2008 $1.17 64.09%
2007 $0.71 500.34%
2006 $0.12 -78.01%
2005 $0.54 168.22%
2004 $0.20 202.40%
2003 $0.07 -21.18%
2002 $0.08 -5.06%
2001 $0.09 83.13%
2000 $0.05 0.00%
EPS pour des entreprises ou concurrents similaires
Entreprise EPS Différence d’EPS Pays
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 $3.62 21.55%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $15.47 419.13%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 $43.12 1,346.98%
US
UCB SA UCB SA
UCB SA
UCB.BR
 $9.62 222.85%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $38.32 1,185.91%
NL